Talk:2C-B: Difference between revisions
>HydroxyPCP Grammatics |
>Unity Reply |
||
(3 intermediate revisions by 3 users not shown) | |||
Line 8: | Line 8: | ||
[[User:Hydroxypcp|Hydroxypcp]] ([[User talk:Hydroxypcp|talk]]) 14:53, 16 November 2017 (CET) | [[User:Hydroxypcp|Hydroxypcp]] ([[User talk:Hydroxypcp|talk]]) 14:53, 16 November 2017 (CET) | ||
:{{ping|Hydroxypcp}} You are right in that the initial wording of the statement was a bit imprecise, or contained some ambiguity. "Derivative" can be a bit of a tricky word as its meaning can differ depending on whether it is used in, say, a strictly modern chemical context, or a looser historical one. I don't think it's necessarily wrong to say that 2C-x is a second-order derivative series of mescaline, with DOx being the first. The team has discussed this matter and decided on a clearer and more accurate way of wording the statement. We hope you find it reasonable. --[[User:Clarity|Clarity]] ([[User talk:Clarity|talk]]) 18:02, 16 November 2017 (CET) | |||
:{{ping|Clarity}} Yes, now it sounds far better. [[User:Hydroxypcp|Hydroxypcp]] ([[User talk:Hydroxypcp|talk]]) 06:14, 17 November 2017 (CET) | |||
== HCl vs HBr == | |||
Both the 2C-B HBr and HCl salts are common and the dosages differ. The HBr dosage is about (consensus is 1.15x or 1.21x) the HCl dosage, and a small change in 2C-B dosage can change the whole nature of the experience. This is pretty important to mention. Thanks. | |||
{{ping|solinium}} Thanks for the suggestion, we'll try to find a way to incorporate this information into the article. --[[User:Clarity|Clarity]] ([[User talk:Clarity|talk]]) 23:56, 21 January 2019 (CET) |